Wormaway 230/20 mg Flavoured Film-Coated Tablets for Cats

Šalis: Airija

kalba: anglų

Šaltinis: HPRA (Health Products Regulatory Authority)

Veiklioji medžiaga:

Pyrantel embonate ; Praziquantel

Prieinama:

Chanelle Pharmaceuticals Manufacturing Limited

ATC kodas:

QP52AA51

INN (Tarptautinis Pavadinimas):

Pyrantel embonate ; Praziquantel

Dozė:

230, 20 mg/tablet

Vaisto forma:

Film-coated tablet

Recepto tipas:

CAM: Companion Animal Medicine as defined in relevant national legislation

Farmakoterapinė grupė:

Cats

Gydymo sritis:

praziquantel, combinations

Terapinės indikacijos:

Endoparasiticide

Autorizacija statusas:

Authorised

Leidimo data:

2013-07-04

Prekės savybės

1
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Wormaway 230/20mg Flavoured film-coated tablets for cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains:
ACTIVE SUBSTANCES:
Pyrantel embonate 230 mg
Praziquantel
20 mg
EXCIPIENTS:
QUALITATIVE COMPOSITION OF EXCIPIENTS AND OTHER CONSTITUENTS
CORE TABLET:
Maize starch
Microcrystalline cellulose
Crospovidone
Magnesium stearate
Colloidal anhydrous silica
FILM COAT
Grilled meat flavour
Opadry II White consisting of Polyvinyl Alcohol, Titanium
Dioxide (E171), Macrogol 3350 and Talc (E553b)
A white to off white round, biconvex coated tablet with a breakline on
one side and plain on the
other side.
The tablet can be divided into two equal parts.
3.
CLINICAL INFORMATION
3.1
TARGET SPECIES
Cats.
3.2
INDICATIONS FOR USE FOR EACH TARGET SPECIES
For the treatment of mixed infections caused by the following
gastrointestinal roundworms and
tapeworms:
ROUNDWORMS: _Toxocara cati_
,
_Toxascaris leonina._
TAPEWORMS: _Dipylidium caninum, Taenia taeniaeformis, Echinococcus
multilocularis._
3.3
CONTRAINDICATIONS
2
Do not use in kittens less than 6 weeks of age.
Do not use in cases of hypersensitivity to the active substances or to
any of the excipients.
3.4
SPECIAL WARNINGS
Fleas serve as intermediate hosts for one common type of tapeworm –
_Dipylidium caninum_
.
Tapeworm infestation is certain to reoccur unless control of
intermediate hosts such as fleas,
mice, etc. is undertaken.
If there is a risk for re-infestation, the advice of a veterinarian
should be sought regarding the
need for and the frequency of repeat administration in cats. Local
epidemiological information
and the living conditions of the cat should be taken into account. It
is also important to remove
sources of possible re-infection such as fleas and mice.
Parasitic resistance to a certain class of anthelmintics can occur
after frequent and repeated use
of an anthelmintic from this class.
3.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for safe use in the target species:
As the tablets